 | Achieve Life Sciences Inc (NASDAQ:ACHV) Short Interest Update
www.americanbankingnews.com - October 11 at 10:20 PM |
| Analysts Expect Achieve Life Sciences Inc (NASDAQ:ACHV) to Post -$0.22 Earnings Per Share
www.americanbankingnews.com - October 10 at 9:19 AM |
| Achieve Life Sciences' (ACHV) Buy Rating Reaffirmed at Maxim Group
www.americanbankingnews.com - October 1 at 4:04 PM |
 | Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study
finance.yahoo.com - September 30 at 8:36 AM |
| Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
finance.yahoo.com - September 13 at 8:47 AM |
| What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)?
finance.yahoo.com - September 9 at 12:01 PM |
| Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
finance.yahoo.com - September 7 at 3:46 PM |
 | Achieve Life Sciences, Inc. Institutional Ownership
www.nasdaq.com - September 2 at 6:51 PM |
| ACHV: SRNT Presentation Next on Agenda
finance.yahoo.com - August 26 at 7:45 PM |
 | Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 9:07 AM |
| /C O R R E C T I O N -- Achieve Life Sciences, Inc./
finance.yahoo.com - August 9 at 9:07 AM |
| Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
finance.yahoo.com - July 30 at 8:47 AM |
| Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
finance.yahoo.com - July 10 at 6:52 PM |
| Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop?
finance.yahoo.com - July 10 at 6:52 PM |
| Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference
finance.yahoo.com - June 21 at 7:36 PM |
| Achieve Life Sciences up 15% premarket after cytisinicline data accepted for presentation
seekingalpha.com - June 21 at 10:33 AM |
| Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
finance.yahoo.com - June 21 at 10:33 AM |
| ACHV: ORCA-1 Topline Results and Comparison
finance.yahoo.com - June 12 at 5:45 PM |
 | Achieve Life Sciences Reports 74-80% Median Reduction In Smoking In Study
feeds.benzinga.com - June 11 at 10:31 AM |
| Achieve Life Sciences up 16% premarket on positive cytisinicline data
seekingalpha.com - June 11 at 8:42 AM |
| Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
finance.yahoo.com - June 11 at 8:42 AM |
| ACHV: 1Q:19 Financial & Operational Update
finance.yahoo.com - May 30 at 6:43 PM |
| Achieve Life Sciences nabs new patent in U.S.; shares up 7% premarket
seekingalpha.com - May 30 at 8:28 AM |
| Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 9:15 AM |
| Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019
finance.yahoo.com - May 15 at 9:00 PM |
| Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
finance.yahoo.com - May 15 at 9:00 PM |
| ACHV: Final Enrollee, Final Visit
finance.yahoo.com - April 26 at 6:57 PM |
| Achieve Life Sciences up 9% premarket as cytisinicline study nears finish line
seekingalpha.com - April 24 at 8:20 AM |
| Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
finance.yahoo.com - April 3 at 8:18 AM |
| Achieve Life Sciences +13% on DSMC review of phase 2b ORCA-1 trial
seekingalpha.com - April 2 at 8:40 AM |
| ACHV: Fiscal Year 2018 Operational and Financial Results
finance.yahoo.com - March 25 at 7:35 PM |
| Achieve Life Sciences, Inc. (ACHV) Pre-Market Trading
www.nasdaq.com - March 19 at 7:46 PM |
| What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline
finance.yahoo.com - March 18 at 8:02 PM |
| Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019
finance.yahoo.com - March 18 at 8:14 AM |
 | Achieve Life Sciences Inc.
www.barrons.com - March 16 at 8:26 AM |
| Achieve Life Sciences up 83% on advancement of cytisinicline - Seeking Alpha
seekingalpha.com - March 15 at 7:30 PM |
| Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 15 at 8:30 AM |
| Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
finance.yahoo.com - March 14 at 7:20 PM |
| ACHV: A Reason to Quit is a Reason to Buy
finance.yahoo.com - March 12 at 10:49 PM |
| Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019
finance.yahoo.com - March 5 at 8:44 AM |
| Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 25 at 8:36 AM |
 | Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial
www.marketwatch.com - February 22 at 7:06 PM |
| Achieve Life Sciences up 57% premarket on positive cytisinicline data
seekingalpha.com - February 22 at 7:06 PM |
| Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting
finance.yahoo.com - February 22 at 8:22 AM |
| Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
finance.yahoo.com - February 20 at 8:24 AM |
| Biocept leads healthcare gainers; Achieve Life Sciences and Revance Therapeutics among losers - Seeking Alpha
seekingalpha.com - January 16 at 5:55 PM |
| 5 Top Rising P/E Stocks to Enjoy Solid Gains
finance.yahoo.com - December 28 at 8:27 AM |
| Achieve Announces Update on Cytisinicline Clinical Development Program
finance.yahoo.com - December 18 at 8:20 AM |
| 5 Top-Ranked Rising P/E Stocks to Lure Investors
finance.yahoo.com - November 28 at 8:25 AM |
| Prometic Life Sciences Inc. (PFSCF) CEO Brad Hansen on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 5:27 PM |
